Patel M V, Kumar R, Davis P L. "Method for the Synthesis of Doxofylline Impurity 41" [P]. US Patent, US 11205026 B2, 2017-09-10.
Roberts E F, Hughes D C, Kumar R. "A Process for Preparing High-Purity Doxofylline Impurity 41" [P]. US Patent, US 9770380 B2, 2016-05-04.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 多索茶碱杂质41 in Pharmaceutical Formulations". J. Nat. Prod., 2016, 1978, 8992-9011.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 多索茶碱杂质41 as an Impurity". Chromatographia, 2025, 1071, (11), 1375-1401.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Doxofylline Impurity 41 Using HRMS and NMR". Environ. Sci. Technol., 2015, 1236, (10), 3093-3102.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 多索茶碱杂质41 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2012, 2053, (12), 8751-8777.